Dipal Doshi
CIK 1613084 · CEO · last filed 2026-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.03M
Companies
3
Total Filings
53
Lifetime Open-Market Net
-$1.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 5 of 6
53 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-12 | TRDA | Sell (S) | −1,788 | -$27.0K | EDGAR |
| 2022-09-06 | TRDA | Grant (A) | +15,125 | $0 | EDGAR |
| 2022-08-31 | TRDA | Sell (S) | −2,000 | -$25.4K | EDGAR |
| 2022-07-29 | TRDA | Sell (S) | −2,000 | -$24.0K | EDGAR |
| 2022-07-06 | TRDA | Grant (A) | — | $0 | EDGAR |
| 2022-06-29 | TRDA | Sell (S) | −4,000 | -$48.0K | EDGAR |
| 2022-03-03 | TRDA | Grant (A) | +30,250 | $0 | EDGAR |
| 2022-01-18 | TRDA | Exer (M) | +10,000 | $17.4K | EDGAR |
| 2021-11-01 | TRDA | Grant (A) | — | $0 | EDGAR |
| 2015-07-09 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +1,706 | -$150.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.